The Wisconsin Economic Development Corp. was a partner with Eli Lilly to meet site selection and workforce needs and the two organizations will continue working together, said Missy Hughes ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

The decision will largely prevent compounding pharmacies from making and selling compounded versions of the drug in the next ...

Chris Schott, an analyst from J.P. Morgan, maintained the Buy rating on Eli Lilly & Co (LLY – Research Report). The associated price target ...

Eli Lilly is joining in a lawsuit filed by the Outsourcing Facilities against the FDA, aiming to reverse the FDA's October 2024 determination that the shortage has been resolved, which would allow ...

The mega-blockbuster weight loss GLP-1 drug is now also approved to treat obstructive sleep apnea in adults with obesity, in combination with diet and exercise.

Why It Matters: The announcement of the $15 billion share buyback and dividend increase comes on the heels of Eli Lilly’s recent $3 billion expansion of its Kenosha County, Wisconsin ...

The expanded facility will focus on manufacturing injectable medicines, device assembly and packaging for medicines across ...

Eli Lilly has announced a $3bn expansion to the US manufacturing facility that it acquired from Nexus Pharmaceuticals earlier this year. The investment in Kenosha County, Wisconsin is aimed at ...

The story of Eli Lilly has, at least recently ... On Dec. 5, it announced a $3 billion expansion of a manufacturing site in Wisconsin that it acquired earlier this year, bringing its total ...

(AP) — Eli Lilly is spending another $3 billion to ... Lilly said Thursday it will expand a Kenosha County, Wisconsin, factory it bought early this year, and the investment will help meet ...